A Randomized, Open-Label, Multicenter, Phase 3 Study To Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination with And/Or Following Chemotherapy in Patients with Previously Untreated Epithelial Ovarian Cancer - Regional Cancer Care Associates LLC

Clinical Trials

A Randomized, Open-Label, Multicenter, Phase 3 Study To Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination with And/Or Following Chemotherapy in Patients with Previously Untreated Epithelial Ovarian Cancer

Type of Cancer
Ovarian Cancer
Locations
Bethesda
Sponsor
Protocol Number
B9991010
Cancer Diagnosis
To Learn More Call
201-510-0910